Workflow
信澳领先增长混合A/C
icon
Search documents
信达澳亚7只权益产品集体斩获五星评级
Cai Fu Zai Xian· 2025-07-14 07:49
Core Insights - The latest fund rating report from Tianxiang Investment Advisory highlights that seven equity products from Xinda Australia Fund Management Co., Ltd. achieved the highest five-star rating due to their long-term stable performance and excellent risk control capabilities [1] - The competition for ratings was intense, with only less than 6% of the 723 actively managed equity funds receiving a five-year five-star rating, and less than 11% and 4% of the 2796 mixed equity funds receiving three-year and five-year five-star ratings, respectively [1] Performance Metrics - Xinda Australia's products, including Xinao Advanced Manufacturing Stock A, Xinao Star Yi Mixed A/C, Xinao New Energy Selected Mixed A, Xinao Medical Health Mixed A, and Xinao Prosperity Preferred Mixed A, all received three-year five-star ratings [1] - Xinao Core Technology Mixed A stood out by receiving both three-year and five-year five-star ratings, showcasing the company's strong performance across multiple products [1] - According to Guotai Junan Securities, as of June 30, 2025, Xinao Advanced Manufacturing Stock A ranked in the top 1/5 percentile of active stock open-end funds over the past five years, placing 66th out of 376 products [1] Investment Strategy - Xinda Australia has been enhancing its investment research system, aiming to establish a benchmark for all categories of equity investment and continuously optimizing its active management capabilities [1] - The company has gathered a team of experienced fund managers with over ten years of practical experience, who are adept at deep research to uncover valuable investment targets, thereby building a solid moat for long-term equity investments [1] Industry Context - The five-star rating has become the "gold standard" for measuring the comprehensive strength of products as the regulatory framework for fund rating systems continues to improve [1] - The collective achievement of seven products by Xinda Australia not only demonstrates the company's "group combat" advantage in equity investment but also sends a positive signal to the market that fundamental research and long-term value investing remain core paths to achieving excess returns in volatile markets [1]